Pyrimidine sulphonamide derivatives as chemokine receptor modulators

Details for Australian Patent Application No. 2005279045 (hide)

Owner AstraZeneca AB

Inventors Cox, Rhona Jane; Preston, Cherylin Francis; Stonehouse, Jeffrey Paul; Cheshire, David Ranulf; Meghani, Premji; Smith, Neal Michael

Agent Freehills

Pub. Number AU-B-2005279045

PCT Pub. Number WO2006/024823

Priority 0419235.7 28.08.04 GB; 0502544.0 08.02.05 GB

Filing date 23 August 2005

Wipo publication date 9 March 2006

Acceptance publication date 26 November 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/5377 (2006.01)

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024823 Priority application(s): WO2006/024823

26 November 2009 Application Accepted

  Published as AU-B-2005279045

25 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005279050-Hybrid QA molecules wherein Q is an aminoquinoline and A is an antibiotic residue, their synthesis and their uses as antibacterial agent

2005279042-Isoxazoline derivatives and their use as herbicides